newstock.ai
← Back

TMOThermo Fisher

$609.82+1.10%Real quote · delayedLife science toolsMedtech & life sciences · 10 peers →

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $44.6B · latest quarter up 10.5% YoY · profitable (FY net income $6.7B) · short activity above its recent average — bears adding.

FY revenue

$44.6B

2025-12

Latest Q YoY

+10.5%

Gross margin

11.9%

FY net income

$6.7B

Diluted EPS

$17.77

Short volume

58.7%

20d avg 47% · shorts building

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

🎯 Market expectations

Expectation reliability High · 80/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$6.40Estimate range $6.37 ~ $6.47 · 8 analysts
History: actual vs consensusavg +4.4%
  • Jun 2026$6.03 vs $5.71+5.6%
  • Mar 2026$5.44 vs $5.20+4.62%
  • Dec 2025$6.57 vs $6.43+2.18%
  • Sep 2025$5.79 vs $5.50+5.27%

The takeaway

This company habitually beats by +4.4% — the next report has to clear that bar to count as good news.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

0 direct · 1 2nd-order · 0 thematic

Ranked by impact strength · strength = estimated move × freshness decay (shorter-lived effects decay faster)

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

The 4 engine calls on this chart (hit / miss / pending) are Pro — price and volume only for nowvolume

📜 Call history (newest first

🔒 Pro only

4 engine calls on this stock — each with direction, magnitude and its verified outcome · sign up to view

Sign up · free 7-day trial →
🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.

Sign up · free 7-day trial →